- Home
- Publications
- Publication Search
- Publication Details
Title
Harnessing the power of antibodies to fight bone metastasis
Authors
Keywords
-
Journal
Science Advances
Volume 7, Issue 26, Pages eabf2051
Publisher
American Association for the Advancement of Science (AAAS)
Online
2021-06-24
DOI
10.1126/sciadv.abf2051
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The bone microenvironment invigorates metastatic seeds for further dissemination
- (2021) Weijie Zhang et al. CELL
- The bone microenvironment increases phenotypic plasticity of ER+ breast cancer cells
- (2021) Igor L. Bado et al. DEVELOPMENTAL CELL
- Bispecific antibodies: a mechanistic review of the pipeline
- (2019) Aran F. Labrijn et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting therapeutics to bone by conjugation with bisphosphonates
- (2018) Robert N Young et al. CURRENT OPINION IN PHARMACOLOGY
- Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes
- (2018) Ikram Ullah et al. JOURNAL OF CLINICAL INVESTIGATION
- Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer
- (2018) Marni B. Siegel et al. JOURNAL OF CLINICAL INVESTIGATION
- Prognostic Factors in Patients with Metastatic Breast Cancer with Bone‐Only Metastases
- (2018) Amanda Parkes et al. ONCOLOGIST
- The Osteogenic Niche Is a Calcium Reservoir of Bone Micrometastases and Confers Unexpected Therapeutic Vulnerability
- (2018) Hai Wang et al. CANCER CELL
- Understanding the Bone in Cancer Metastasis
- (2018) Jaime Fornetti et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of Bone Targeting Drugs
- (2017) Molly Stapleton et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bone-in-culture array as a platform to model early-stage bone metastases and discover anti-metastasis therapies
- (2017) Hai Wang et al. Nature Communications
- Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations
- (2017) David Brown et al. Nature Communications
- Survival after bone metastasis by primary cancer type: a Danish population-based cohort study
- (2017) Elisabeth Svensson et al. BMJ Open
- Targeted delivery to bone and mineral deposits using bisphosphonate ligands
- (2016) Lisa E. Cole et al. ADVANCED DRUG DELIVERY REVIEWS
- Antibody drug conjugates: lessons from 20 years of clinical experience
- (2016) A. W. Tolcher ANNALS OF ONCOLOGY
- Trastuzumab-deBouganin Conjugate Overcomes Multiple Mechanisms of T-DM1 Drug Resistance
- (2016) Rachelle L. Dillon et al. JOURNAL OF IMMUNOTHERAPY
- The Osteogenic Niche Promotes Early-Stage Bone Colonization of Disseminated Breast Cancer Cells
- (2015) Hai Wang et al. CANCER CELL
- A cell–ECM screening method to predict breast cancer metastasis
- (2015) L. E. Barney et al. Integrative Biology
- The critical role of bisphosphonates to target bone cancer metastasis: an overview
- (2014) Tejinder Singh et al. JOURNAL OF DRUG TARGETING
- HER2 Drives Luminal Breast Cancer Stem Cells in the Absence of HER2 Amplification: Implications for Efficacy of Adjuvant Trastuzumab
- (2013) S. Ithimakin et al. CANCER RESEARCH
- Durable complete response following chemotherapy and trastuzumab for metastatic HER2-positive breast cancer
- (2012) G. Gullo et al. ANNALS OF ONCOLOGY
- Antibody-Drug Conjugates in Cancer Therapy
- (2012) Eric L. Sievers et al. Annual Review of Medicine
- SnapShot: Bone Metastasis
- (2012) Brian Ell et al. CELL
- Development of Novel Bisphosphonate Prodrugs of Doxorubicin for Targeting Bone Metastases That Are Cleaved pH Dependently or by Cathepsin B: Synthesis, Cleavage Properties, and Binding Properties to Hydroxyapatite As Well As Bone Matrix
- (2012) Katrin Hochdörffer et al. JOURNAL OF MEDICINAL CHEMISTRY
- The relationship between the chemistry and biological activity of the bisphosphonates
- (2011) Frank H. Ebetino et al. BONE
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter Phase III Randomized Trial Comparing Docetaxel and Trastuzumab With Docetaxel, Carboplatin, and Trastuzumab As First-Line Chemotherapy for Patients WithHER2-Gene-Amplified Metastatic Breast Cancer (BCIRG 007 Study): Two Highly Active Therapeutic Regimens
- (2010) Vicente Valero et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunotoxicity of monoclonal antibodies
- (2010) Jacques Descotes mAbs
- The safety and side effects of monoclonal antibodies
- (2010) Trevor T. Hansel et al. NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now